Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

Glaucoma Treatment MarketThe global glaucoma treatment market, valued at USD 5.7 billion in 2022, is projected to grow at a CAGR of 3.18% during the forecast period, reaching an estimated USD 8.0 ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

In an era where health and wellness are prioritized more than ever, the quest for effective natural remedies has led many to ...

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder where the immune system attacks peripheral nerves, causing ...

In an international effort, researchers at Western University, the University of Maryland School of Dentistry (UMSOD) and Neuroscience Research Australia (NeuRA) uncovered how specific patterns in ...

Some health problems, including chronic pain, inflammation and neurological diseases, can be treated by nerve stimulation, ...